supp.fit

Vitamin B12 and Vitamin B6: study protocols

156 study groups took Vitamin B12 together with Vitamin B6. These are the doses the studies gave. They are not a recommendation.

Vitamin B12: what the research found →

Dose per serving from research: Vitamin B12

156 study groups in 133 studies say how much Vitamin B12 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mcg to 500 mcg, 43% of 156 study groups.

Daily doseStudy groups
1 mcg or less
2
1 mcg to 2.5 mcg
12
2.5 mcg to 5 mcg
11
5 mcg to 10 mcg
10
10 mcg to 25 mcg
6
25 mcg to 50 mcg
4
50 mcg to 100 mcg
3
100 mcg to 250 mcg
0
250 mcg to 500 mcg
67
500 mcg to 1 mg
34
over 1 mg
7

Dose per serving from research: Vitamin B6

153 study groups in 132 studies say how much Vitamin B6 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 25 mg to 50 mg, 38% of 153 study groups.

Daily doseStudy groups
500 mcg or less
1
500 mcg to 1 mg
8
1 mg to 2.5 mg
12
2.5 mg to 5 mg
22
5 mg to 10 mg
16
10 mg to 25 mg
25
25 mg to 50 mg
58
50 mg to 100 mg
7
over 100 mg
4

Commonly used together

155 of 156 study groups took Vitamin B12 and Vitamin B6 with something else. Shown: what 3 or more different studies gave. The 10 most common of 21.

What was given together, not what works together.

Taken withStudy groups
Folic Acid
124
Riboflavin
22
Thiamine
19
Vitamin D
17
Vitamin E
16
Vitamin C
14
Zinc
13
Vitamin B9
12
Iron
10
Calcium
9

156 study groups

Study
B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
2010 · B vitamins · Patients with recent stroke or transient ischaemic attack within the past 7 months
500 mcg25 mg1241 days4,089
Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebo-controlled trial
2012 · B vitamins · Patients with recent stroke or transient ischemic attack
500 mcg25 mg1241 days4,082
Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial
2012 · B-vitamins group · Adults with a stroke or transient ischaemic attack within the previous 7 months; men and women, age not restricted
500 mcg25 mg1241 days4,040
Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial
2008 · Active treatment · Women aged 40 years or older with a history of cardiovascular disease or at least three cardiovascular risk factors
1 mg50 mg2665 days2,721
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study
2009 · folic acid/B6/B12 group · Women at high risk of cardiovascular disease, with preexisting cardiovascular disease or at least three coronary risk factors; women included in these AMD analyses had no AMD diagnosis at baseline.
1 mg50 mg2665 days2,607
Effect of homocysteine-lowering treatment with folic Acid and B vitamins on risk of type 2 diabetes in women: a randomized, controlled trial
2009 · Active treatment · Women aged 45 years or older at high risk for cardiovascular disease, without diabetes at baseline
1 mg50 mg2665 days2,132
Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-Related Cataract in a Randomized Trial of Women
2016 · combination treatment group · Women with preexisting cardiovascular disease or at least three coronary risk factors; ages 40 and older
1 mg50 mg2665 days1,969
B vitamins to enhance treatment response to antidepressants in middle-aged and older adults: results from the B-VITAGE randomised, double-blind, placebo-controlled trial
2014 · vitamins · Community-dwelling adults aged 50 years or over with DSM-IV-TR major depression
500 mcg25 mg52 weeks77
Homocysteine lowering with folic acid and B vitamins in vascular disease
2006 · active-treatment group · Patients aged 55 years or older with vascular disease or diabetes
1 mg50 mg5 years—
Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial
2008 · combined folic acid/vitamin B6/vitamin B12 treatment · Women aged 40 years or older with a history of cardiovascular disease or at least three coronary risk factors
1 mg50 mg2666 days—
Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial
2009 · vitamin therapy group · Adults with known cardiovascular disease
1 mg50 mg5 years—
B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial
2010 · B-vitamins · Stroke survivors; age and sex not specified
500 mcg25 mg383 days—
Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study
2009 · Group DB (combination therapy) · Adults with acute lumbago
2 mg100 mg7 days187
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial
2008 · folic acid plus vitamin B12 plus vitamin B6 · Adults undergoing coronary angiography with coronary artery disease or aortic valve stenosis
400 mcg40 mg165 weeks772
Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial
2002 · homocysteine-lowering therapy · Patients with coronary artery disease after successful percutaneous coronary intervention; age and sex not specified
400 mcg10 mg26 weeks272
Effectiveness of homocysteine lowering vitamins in prevention of thrombotic tendency at high altitude area: A randomized field trial
2015 · intervention · Indian soldiers freshly inducted to a high-altitude area
1 mg3 mg2 years—
Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis
2013 · B-vitamins · Patients with previous stroke or transient ischemic attack who were cognitively unimpaired at the cognitive assessment
500 mcg25 mg1241 days1,110
A Randomized Control Trial of Dexketoprofen/Vitamin B (Thiamine, Pyridoxine and Cyanocobalamin) Fixed-Dose Combination in Post-Traumatic Grade I-II Cervical Sprains
2024 · Dexketoprofen/vitamin B · Adults aged 18 years or older, both sexes, with grade I–II post-traumatic cervical sprain and acute pain
1.5 mg150 mg7 days83
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease
2008 · B vitamin group · Women aged 65 years or older with cardiovascular disease or at least three coronary risk factors; female health professionals
1 mg50 mg2411 days—
Efficacy and tolerability of advanced glycation end-products inhibitor in osteoarthritis: a randomized, double-blind, placebo-controlled study
2013 · AGEs inhibitor (drug) group · Adults with primary osteoarthritis meeting American College of Rheumatology classification criteria; mean age 57.26 years; 26 women and 4 men in the study overall
1.5 mg150 mg24 weeks—
Effects of multimicronutrient supplementation on helminth reinfection: a randomized, controlled trial in Kenyan schoolchildren
2003 · multimicronutrient supplementation · Schoolchildren in Nyanza Province, Kenya; age and sex not specified
2 mcg1.7 mg335 days—
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Multiple micronutrients · Pregnant women in rural Nepal
2.6 mcg2.2 mg——
Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension
2005 · Multivitamin plus vitamin A · HIV-positive pregnant Tanzanian women
50 mcg25 mg——
Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension
2005 · Multivitamin without vitamin A · HIV-positive pregnant Tanzanian women
50 mcg25 mg——
Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis
2013 · AGE-S · Subjects evaluated for coronary artery calcium; age, sex, and specific condition are not stated
100 mcg12.5 mg1 year—
Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study
2009 · vitamin group · Adults aged 21 years or older with advanced chronic kidney disease or end-stage renal disease and high plasma homocysteine
2 mg100 mg1128 days339
High-dose B vitamin supplementation and progression of subclinical atherosclerosis: a randomized controlled trial
2009 · B-vitamin group · Men and postmenopausal women aged 40 years or older with fasting total homocysteine ≥8.5 μmol/L and no clinical signs or symptoms of cardiovascular disease
400 mcg50 mg1132 days254
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial
2008 · high-dose supplement group · Adults over 50 with mild to moderate probable Alzheimer disease and normal vitamin B12 and folate levels
1 mg25 mg548 days240
[Results of a double-blind study of diclofenac + vitamin B1, B6, B12 versus diclofenac in patients with acute pain of the lumbar vertebrae. A multicenter study]
1990 · Diclofenac plus vitamins B1, B6, and B12 · Patients with acute pain of the lumbar vertebrae; age and sex not specified
1.5 mg300 mg2 weeks184
Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial
2008 · treatment with vitamins · Men aged 75 years and older, free of clinically significant depression at baseline
400 mcg25 mg2 years150
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial
2012 · B-vitamin group · Adults aged 70 years or older with mild cognitive impairment
500 mcg20 mg2 years133
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
2010 · Active treatment group · Adults aged 70 years or older with mild cognitive impairment
500 mcg20 mg2 years85
Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease
2012 · combined therapy · Patients with cardiovascular disease at high cardiovascular risk; age and sex not reported
400 mcg10 mg6 weeks36
Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease
2012 · group V · Patients with cardiovascular disease at high cardiovascular risk; age and sex not reported
400 mcg10 mg6 weeks18
Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study
2005 · Vitamin therapy · Community-dwelling elderly adults, median age 76 years; both sexes; vitamin deficiencies were present in a subset
500 mcg3 mg120 days—
Clinical trial: B vitamins improve health in patients with coeliac disease living on a gluten-free diet
2009 · B vitamin supplementation · Adults aged 45–64 years with longstanding coeliac disease, on a strict gluten-free diet for several years
500 mcg3 mg26 weeks—
Coronary blood flow in patients with stable coronary artery disease treated long term with folic acid and vitamin B12
2011 · Folic acid and vitamin B12 plus vitamin B6 · Adults with stable coronary artery disease; mean age 57.8 years; sex not specified
400 mcg40 mg2 years—
B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial
2014 · B vitamins only · Adults aged 45–80 with a recent history of myocardial infarction, unstable angina, or ischemic stroke
20 mcg3 mg1716 days—
B-Vitamin Therapy for Kidney Transplant Recipients Lowers Homocysteine and Improves Selective Cognitive Outcomes in the Randomized FAVORIT Ancillary Cognitive Trial
2017 · treatment group (high-dose vitamin group) · Men and women aged 35–75 with stable kidney function for at least 6 months after kidney transplantation and elevated plasma homocysteine
1 mg50 mg2008 days—
The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B(12), B(6), and Folic Acid on Symptoms and Neurocognition in First-Episode Psychosis
2019 · B-vitamin supplement group · Patients with first-episode psychosis; age and sex not specified
400 mcg50 mg12 weeks—
Effect of zinc plus multivitamin supplementation on growth in school children
2016 · Chelated zinc plus multivitamins · Healthy Thai schoolchildren aged 4–13 years
10 mcg1 mg26 weeks70
Investigating the Effects of a Multinutrient Supplement on Cognition, Mood and Biochemical Markers in Middle-Aged Adults with 'Optimal' and 'Sub-Optimal' Diets: A Randomized Double Blind Placebo Controlled Trial
2022 · active supplementation · Adults aged 40–65 years, healthy and without neurological, cognitive, mood or psychiatric disorders; participants had either an optimal or sub-optimal diet
50 mcg41.1 mg12 weeks70
Effect of a Combination of Magnesium, B Vitamins, Rhodiola, and Green Tea (L-Theanine) on Chronically Stressed Healthy Individuals-A Randomized, Placebo-Controlled Study
2022 · Mg-Teadiola · Adults aged 18–65, either sex, otherwise healthy and chronically stressed (DASS-42 stress score ≥14)
1.25 mcg700 mcg4 weeks51
Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients
2007 · mecobalamin (B12) + multivitamin supplement · Taiwanese men and women aged over 50 with mild to moderate Alzheimer's disease and normal folic acid and vitamin B12 concentrations
500 mg5 mg26 weeks45
L-Arginine and B vitamins improve endothelial function in subjects with mild to moderate blood pressure elevation
2018 · Nutritional intervention group · Men and postmenopausal women aged 40–65 with slightly to moderately elevated blood pressure
2 mcg3 mg26 weeks40
L-Arginine and B vitamins improve endothelial function in subjects with mild to moderate blood pressure elevation
2018 · Placebo group receiving open-label TAP in follow-up · Men and postmenopausal women aged 40–65 with slightly to moderately elevated blood pressure
2 mcg3 mg13 weeks40
Effects of Low-Dose Dairy Protein Plus Micronutrient Supplementation during Resistance Exercise on Muscle Mass and Physical Performance in Older Adults: A Randomized, Controlled Trial
2018 · ExPM (resistance exercise plus low-dose dairy protein and micronutrient supplementation) · Adults aged 65–80 years, non-disabled and not exercising regularly
12 mcg6 mg12 weeks40
Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
2024 · 10-element combination tablet · Overweight or obese adults with type 2 diabetes and mild-to-moderate painful diabetic neuropathy; mean age 63 years
5 mcg3 mg26 weeks36
A functional evaluation of anti-fatigue and exercise performance improvement following vitamin B complex supplementation in healthy humans, a randomized double-blind trial
2023 · Ex PLUS® group · Healthy male and female non-athletes aged 20–30
750 mcg50 mg4 weeks32
Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study
2025 · addOPC group · Adults with Parkinson's disease receiving levodopa-carbidopa intestinal gel and experiencing nocturnal, morning, or afternoon akinesia
5 mcg3 mg1 year11
Opicapone in Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel Treatment: A Pilot, Randomized Study
2025 · nOPC group · Adults with Parkinson's disease receiving levodopa-carbidopa intestinal gel and experiencing nocturnal, morning, or afternoon akinesia
5 mcg3 mg1 year11
Improving neuropathy scores in type 2 diabetic patients using micronutrients supplementation
2011 · Group MVB · Patients with type 2 diabetes
10 mcg10 mg120 days—
B vitamin and/or n-3 fatty acid supplementation and health-related quality of life: ancillary findings from the SU.FOL.OM3 randomized trial
2014 · B vitamins plus n-3 fatty acids · Adults aged 45–80 with a recent history of myocardial infarction, unstable angina, or ischemic stroke
20 mcg3 mg1716 days—
Three-month B vitamin supplementation in pre-school children affects folate status and homocysteine, but not cognitive performance
2014 · B vitamin supplementation group · Healthy preschool children selected for low urinary folate-status ranking
1.2 mcg730 mcg90 days—
Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly
2015 · treatment group · Healthy adults aged 60–74 years
10 mcg2 mg1 year—
Lowering homocysteine with B vitamins has no effect on blood pressure in older adults
2007 · Vitamins group · Healthy adults aged 65 years or older with homocysteine concentrations of at least 13 micromol/L
500 mcg10 mg2 years—
A 2-Year Randomized Controlled Trial With Low-Dose B-Vitamin Supplementation Shows Benefits on Bone Mineral Density in Adults With Lower B12 Status
2022 · B-vitamin treatment · Community-dwelling adults aged 50 years or older; men and women; no specific diagnosed condition, and not currently taking B-vitamin supplements at screening
10 mcg10 mg2 years103
Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial
2009 · AGE+S · Intermediate-risk adults, mean age 60 ± 9 years; 79% male
100 mcg12.5 mg1 year—
Effect of Combined Treatment With Folic Acid, Vitamin B(6), and Vitamin B(12) on Plasma Biomarkers of Inflammation and Endothelial Dysfunction in Women
2018 · Folic Acid/B6/B12 · Adult women at increased cardiovascular risk, with pre-existing cardiovascular disease or at least three coronary risk factors
1 mg50 mg2665 days150
Preoperative oral B vitamins prevent nitrous oxide-induced postoperative plasma homocysteine increases
2001 · Vitamin group · Patients undergoing elective revision knee or hip arthroplasty, scheduled for surgery lasting longer than 3 hours
500 mcg25 mg7 days—
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial
2005 · vitamin therapy · Patients with recent transient ischemic attack or stroke; age and sex not reported
500 mcg25 mg26 weeks—
Sustained homocysteine-lowering effect over time of folic acid-based multivitamin therapy in stroke patients despite increasing folate status in the population
2005 · active VITATOPS medication · Patients with stroke or transient ischemic attack
500 mcg25 mg26 weeks—
Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, Vitamins B6 and B12
2005 · treatment group · Adults aged 60 ± 8 years with carotid intima-media thickness ≥1 mm and at risk of cerebral ischemia
500 mcg25 mg1 year—
Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial
2009 · B-vitamin therapy · Adults with a history of ischemic stroke
500 mcg25 mg1461 days—
Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial
2010 · B-vitamin group · People with type 1 or type 2 diabetes and a clinical diagnosis of diabetic nephropathy
1 mg25 mg3 years—
Folic acid causes higher prevalence of detectable unmetabolized folic acid in serum than B-complex: a randomized trial
2016 · B-complex · Elderly people
10 mcg8 mg23 days27
Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid
2002 · Folic acid group · Adults with chronic stable hemodialysis and hyperhomocysteinemia
1 mg50 mg12 weeks24
Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid
2002 · Folinic acid group · Adults with chronic stable hemodialysis and hyperhomocysteinemia
1 mg50 mg12 weeks22
Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study
2002 · Vitamin B(12), folic acid, and vitamin B(6) · Patients aged 38–80 years undergoing coronary angiography
400 mcg40 mg12 weeks—
Plasma vitamin B6 vitamers before and after oral vitamin B6 treatment: a randomized placebo-controlled study
2003 · Group A · Patients aged 38–80 years undergoing coronary angiography
400 mcg40 mg12 weeks—
One year B-vitamins increases serum and whole blood folate forms and lowers plasma homocysteine in older Germans
2015 · B-vitamin supplementation · Older German adults, mean age 67 years
500 mcg50 mg1 year—
Maternal B-vitamin and vitamin D status before, during, and after pregnancy and the influence of supplementation preconception and during pregnancy: Prespecified secondary analysis of the NiPPeR double-blind randomized controlled trial
2023 · intervention · Women planning pregnancy; generally healthy, recruited before conception
5.2 mcg2.6 mg—870
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
2015 · Active group (RCT1, RCT2 and RCT3) · Men and women aged 50 years or older with mild or mild-to-moderate Alzheimer's disease; RCT3 participants were on stable approved Alzheimer's medication, while RCT1 and RCT2 participants were drug-free for Alzheimer's medication.
3 mcg1 mg24 weeks501
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
2015 · Active product during open-label extension (OLE) · Men and women aged 50 years or older with mild Alzheimer's disease who completed RCT2.
3 mcg1 mg24 weeks201
Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh
2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified
2.6 mcg1.9 mg—176
Daily supplementation of a multiple micronutrient powder improves folate but not thiamine, riboflavin, or vitamin B(12) status among young Laotian children: a randomized controlled trial
2022 · micronutrient powder group (MNP) · Children aged 6–23 months in rural Lao PDR; no disease-based selection, with high prevalence of undernutrition and micronutrient deficiencies
0.9 mcg500 mcg36 weeks130
Lowering plasma homocysteine concentrations of older men and women with folate, vitamin B-12, and vitamin B-6 does not affect the proportion of (n-3) long chain polyunsaturated fatty acids in plasma phosphatidylcholine
2008 · vitamin group · Men and women aged 65 years or older with plasma homocysteine concentrations of at least 13 micromol/L
500 mcg10 mg2 years127
Multiple micronutrient supplementation improves vitamin B₁₂ and folate concentrations of HIV infected children in Uganda: a randomized controlled trial
2011 · Multiple micronutrient supplementation (MMS) · HIV-infected children aged 1–5 years
2.4 mcg1.2 mg26 weeks104
Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment
2021 · B-vitamin group · Men and women, mean age 77.6 years, with mild cognitive impairment
500 mcg20 mg2 years95
Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial
2015 · high-dose B vitamin supplementation · Adults aged 70 years or older with mild cognitive impairment
500 mcg20 mg2 years85
Effects of Multivitamin, Multimineral and Phytonutrient Supplementation on Nutrient Status and Biomarkers of Heart Health Risk in a Russian Population: A Randomized, Double Blind, Placebo Controlled Study
2018 · VMP (Nutrilite Double X™) · Generally healthy adults aged 40–70 years in Moscow with low habitual recommended-food intake (recommended food score <12), predominantly women; no chronic diseases
2 mcg3 mg8 weeks60
Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease
2022 · Folic acid + vitamins B12, B6 · Adults with suspected coronary artery disease undergoing angiography for stable angina; mean age 61.2 years, 71.5% male
400 mcg40 mg1387 days52
[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial]
2005 · Supraphysiological daily-dose regimen · Adults with stable maintenance hemodialysis (mean age 68 years; 48% male)
1 mg100 mg1 year33
A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels
2019 · Natural vitamin B complex (group N) · Healthy adults; age range and sex not specified
8.85 mcg3.38 mg6 weeks30
A Randomized Pilot Trial to Evaluate the Bioavailability of Natural versus Synthetic Vitamin B Complexes in Healthy Humans and Their Effects on Homocysteine, Oxidative Stress, and Antioxidant Levels
2019 · Synthetic vitamin B complex (group S) · Healthy adults; age range and sex not specified
8.85 mcg3.38 mg6 weeks30
Plasma homocysteine and markers for oxidative stress and inflammation in patients with coronary artery disease--a prospective randomized study of vitamin supplementation
2005 · open therapy with vitamins · Adults with ischemic heart disease and plasma homocysteine at least 15.0 micromol/L
1 mg40 mg90 days29
The impact of folate status and folic acid supplementation on the micronucleus frequency in human erythrocytes
2006 · folic acid, vitamin B12 and vitamin B6 supplementation group · Both-sex participants without folate deficiency; age not reported
20 mcg4 mg7 days29
Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients
2003 · group A · Adults with hyperhomocysteinemia who were stable renal-transplant recipients
400 mcg50 mg26 weeks28
[Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial]
2005 · Daily renal multivitamin regimen · Adults with stable maintenance hemodialysis (mean age 68 years; 48% male)
400 mcg10 mg1 year27
Effect of Methylfolate, Pyridoxal-5'-Phosphate, and Methylcobalamin (Soloways(TM)) Supplementation on Homocysteine and Low-Density Lipoprotein Cholesterol Levels in Patients with Methylenetetrahydrofolate Reductase, Methionine Synthase, and Methionine Synthase Reductase Polymorphisms: A Randomized Controlled Trial
2024 · methylfolate, P5P, and methylcobalamin · Adults aged 40–75 with elevated homocysteine, LDL-C of 70–190 mg/dL, and at least one minor allele in a specified MTHFR, MTR, or MTRR polymorphism
1 mg100 mg180 days27
Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2000 · FA group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
1 mg50 mg12 weeks25
Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2000 · MTHF group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
1 mg50 mg12 weeks25
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · MTHF group · Adults with chronic, stable hyperhomocysteinemia receiving maintenance hemodialysis
1 mg50 mg12 weeks25
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Folic acid group · Adults with chronic, stable hyperhomocysteinemia receiving maintenance hemodialysis
1 mg50 mg12 weeks25
Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2001 · L-folinic acid group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
1 mg50 mg12 weeks24
Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients
2001 · Folic acid group · Adults with chronic, stable hyperhomocysteinemia receiving hemodialysis
1 mg50 mg12 weeks24
B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke
2004 · B-group vitamin supplements · Patients with acute ischaemic stroke, enrolled within 12 hours of symptom onset; age and sex not specified
400 mcg50 mg2 weeks24
Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial
2006 · B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset
400 mcg50 mg2 weeks24
Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial
2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset
400 mcg50 mg2 weeks24
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients
1999 · group 1 · Chronic, stable renal transplant recipients; age and sex not stated
400 mcg50 mg12 weeks20
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients
1999 · group 2 · Chronic, stable renal transplant recipients; age and sex not stated
400 mcg50 mg12 weeks20
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipients
1999 · group 3 · Chronic, stable renal transplant recipients; age and sex not stated
400 mcg50 mg12 weeks20
Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial
2005 · group 2 · Women with polycystic ovarian syndrome treated with metformin; age not reported
2 mg500 mg90 days20
Hyperhomocysteinemia and endothelial function in young subjects: effects of vitamin supplementation
2002 · vitamin supplementation · Male volunteers aged 40 years or younger; nine matched pairs received vitamins, including hyperhomocysteinemic and normohomocysteinemic subjects
800 mcg2 mg8 weeks18
[Treatment of hyperhomocysteinemia and endothelial dysfunction in renal-transplant recipients with vitamin B]
2005 · vitamin treatment (group A) · Stable hyperhomocysteinemic renal-transplant recipients
1 mg50 mg26 weeks18
Fortified breakfast cereal consumed daily for 12 wk leads to a significant improvement in micronutrient intake and micronutrient status in adolescent girls: a randomised controlled trial
2016 · Fortified cereal, morning · Females aged 16–19 years who regularly skipped breakfast and had low riboflavin status and haemoglobin; no diagnosed illness
1.45 mcg1.74 mg12 weeks18
Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial
2020 · DHA treatment arm · Cognitively unimpaired men and women aged 55 years and older with a first-degree family history of dementia
1 mg100 mg26 weeks18
Fortified breakfast cereal consumed daily for 12 wk leads to a significant improvement in micronutrient intake and micronutrient status in adolescent girls: a randomised controlled trial
2016 · Fortified cereal, evening · Females aged 16–19 years who regularly skipped breakfast and had low riboflavin status and haemoglobin; no diagnosed illness
1.45 mcg1.74 mg12 weeks16
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Renal transplant recipients · Renal transplant recipients with hyperhomocysteinemia
400 mcg50 mg12 weeks10
Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial
1997 · vitamin B6, folic acid, and vitamin B12 · Clinically stable renal transplant recipients
400 mcg50 mg—7
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Hemodialysis patients receiving folic acid · Hemodialysis patients with hyperhomocysteinemia and baseline total homocysteine comparable to the renal transplant recipients
1 mg50 mg12 weeks—
Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients
2001 · Hemodialysis patients receiving MTHF · Hemodialysis patients with hyperhomocysteinemia and baseline total homocysteine comparable to the renal transplant recipients
1 mg50 mg12 weeks—
Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate
2001 · fenofibrate plus vitamins · men with hyperlipidemia
50 mcg5 mg6 weeks—
Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12
2002 · Group 1 · Chronic haemodialysis patients; age and sex not specified
429 mcg—26 weeks—
Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12
2002 · Group 2 · Chronic haemodialysis patients; age and sex not specified
429 mcg—26 weeks—
Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12
2002 · Group 3 · Chronic haemodialysis patients; age and sex not specified
429 mcg—26 weeks—
Effect of homocysteine reduction by B-vitamin supplementation on markers of clotting activation
2002 · high-dose B-vitamin supplements · Healthy volunteers with homocysteine >16 μmol/L or ≤16 μmol/L
400 mcg50 mg8 weeks—
Reduction of plasma homocysteine and serum methylmalonate concentrations in apparently healthy elderly subjects after treatment with folic acid, vitamin B12 and vitamin B6: a randomised trial
2003 · B-vitamin treatment · Community-dwelling apparently healthy adults aged 70–93 years; median age 76 years
500 mcg3 mg120 days—
Mineral water fortified with folic acid, vitamins B6, B12, D and calcium improves folate status and decreases plasma homocysteine concentration in men and women
2004 · Fortified mineral water · Free-living men and women without folate deficiency or elevated homocysteine
7.5 mcg1 mg8 weeks—
Breakfast cereal fortified with folic acid, vitamin B-6, and vitamin B-12 increases vitamin concentrations and reduces homocysteine concentrations: a randomized trial
2004 · Fortified cereal group · Volunteers aged 50–85 years without the listed medical conditions who did not regularly use multiple or B-vitamin supplements or highly fortified breakfast cereal
4.8 mcg1.8 mg12 weeks—
The effect of homocysteine reduction by B-vitamin supplementation on markers of endothelial dysfunction
2004 · B-vitamins · Healthy volunteers, including hyperhomocysteinemic and normohomocysteinemic participants
400 mcg50 mg8 weeks—
Efficacy of B vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia
2006 · Vitamin group · Community-dwelling men aged 75 years or older
400 mcg25 mg2 years—
Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients
2006 · Treatment group · Chronic hemodialysis patients with hyperhomocysteinemia; age and sex not specified
1 mg50 mg26 weeks—
Effect of fortified spread on homocysteine concentration in apparently healthy volunteers
2007 · spread 1 · Apparently healthy adult volunteers; 50% male; age range not reported
2 mcg1 mg6 weeks—
Effect of fortified spread on homocysteine concentration in apparently healthy volunteers
2007 · spread 2 · Apparently healthy adult volunteers; 50% male; age range not reported
2 mcg1 mg6 weeks—
Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease
2007 · A: folic acid/vitamin B12/vitamin B6 · Adults aged 38–80 with suspected coronary artery disease
400 mcg40 mg26 weeks—
Treatment of hyperhomocysteinemia and endothelial dysfunction in renal transplant recipients with B vitamins in the Chinese population
2008 · folate treatment · Chinese renal transplant recipients with hyperhomocysteinemia; age and sex not reported
1 mg50 mg26 weeks—
Effect of homocysteine-lowering therapy on arterial elasticity and metabolic parameters in metformin-treated diabetic patients
2008 · group 1 · Adults with diabetes treated with high-dose metformin
400 mcg10 mg120 days—
Serum biomarkers for atrophic gastritis and antibodies against Helicobacter pylori in the elderly: Implications for vitamin B12, folic acid and iron status and response to oral vitamin therapy
2008 · oral vitamin treatment · Community-dwelling adults, mean age 76 years
500 mcg3 mg120 days—
The effects of vitamin supplementation and MTHFR (C677T) genotype on homocysteine-lowering and migraine disability
2009 · vitamin supplementation · patients diagnosed with migraine with aura; age and sex not reported
400 mcg25 mg26 weeks—
Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations
2010 · vitamins group · Healthy adults aged 65 years or older with elevated homocysteine (>13 micromol/l)
500 mcg10 mg2 years—
Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment
2013 · B-vitamin treatment · Elderly adults with mild cognitive impairment and increased dementia risk
500 mcg20 mg2 years—
The association between progression of atherosclerosis and the methylated amino acids asymmetric dimethylarginine and trimethyllysine
2013 · Folic acid plus vitamin B12 plus vitamin B6 · Adults with suspected or established coronary artery disease who underwent coronary angiography; median age 60 years
400 mcg40 mg316 days—
MTHFR 677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial
2018 · Group A: B-vitamins · Adults with a history of cardiovascular disease, including men and women; mean age 61.3 years
20 mcg3 mg1716 days—
Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial
2019 · folic acid + vitamin B12 + vitamin B6 · Adults with suspected coronary artery disease who underwent coronary angiography; mean age about 61 years, 69.8% male
400 mcg40 mg165 weeks—
Vitamin requirements for the treatment of hyperhomocysteinemia in humans
1994 · combination of folic acid, vitamin B-12 and vitamin B-6 · men with hyperhomocysteinemia
400 mcg10 mg6 weeks—
Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
1993 · daily vitamin supplement · Apparently healthy men with moderate hyperhomocysteinemia
400 mcg10 mg6 weeks—
Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers
1998 · high-dose multivitamin supplements · Patients with a history of recurrent venous thrombosis and hyperhomocysteinemic healthy volunteers
400 mcg50 mg——
A novel nutritional supplement to reduce plasma homocysteine in nonpregnant women: A randomised controlled trial in The Gambia
2019 · UNIMMAP tablet · Nonpregnant, non-lactating healthy women aged 18–45 years in West Kiang, The Gambia; women of reproductive age with common micronutrient deficiencies in the population
2.6 mcg1.9 mg12 weeks105
Randomised Controlled Trial of Nutritional Supplement on Bone Turnover Markers in Indian Premenopausal Women
2021 · test group · Premenopausal Indian women aged 25–45 years in good general health, with BMI 18–30 kg/m²
1 mcg2 mg180 days57
Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial
2016 · Normocis 400® group · Adults with stage 1 essential hypertension and hyper-homocysteinemia (HCys ≥15 μmol/L), without a history of cardiovascular or cerebrovascular disease; mean age 62.8 years, 63.5% male
5 mcg3 mg60 days52
Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD
2009 · Treatment group · Adults with stage 2 to 4 chronic kidney disease and creatinine clearance of 15 to 70 mL/min/1.73 m²
1 mg100 mg2 years47
Effects of low-dose B vitamins plus betaine supplementation on lowering homocysteine concentrations among Chinese adults with hyperhomocysteinemia: a randomized, double-blind, controlled preliminary clinical trial
2023 · supplement group · Chinese adults aged 18–65 with hyperhomocysteinemia (blood homocysteine 15–100 μmol/L)
6.4 mcg8 mg12 weeks44
Effect of adding B-vitamins to vitamin D and calcium supplementation on CpG methylation of epigenetic aging markers
2018 · D + Ca + B · Adults, mean age 68.4 years; no specific condition stated
500 mcg50 mg1 year32
Plasma trimethylamine-N-oxide following supplementation with vitamin D or D plus B vitamins
2017 · vitamin D + B arm · Participants; age, sex, and health condition not specified
500 mcg50 mg1 year25
Metabolic consequences of discretionary fortified beverage consumption containing excessive vitamin B levels in adolescents
2019 · fortified beverage (FB) · Healthy adolescents aged 13–19 years, male and female
500 mcg40 mg1 day20
High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients
1996 · Supraphysiologic-dose B-vitamin supplementation · Hyperhomocysteinemic dialysis patients
1 mg100 mg8 weeks15
Total homocysteine lowering treatment among coronary artery disease patients in the era of folic acid-fortified cereal grain flour
2002 · Folic acid, riboflavin, and vitamin B12 with vitamin B6 · Adults with stable coronary artery disease; mean age 60.1 years; 29.8% women
400 mcg50 mg12 weeks—
Folate therapy and in-stent restenosis after coronary stenting
2004 · folate group · Patients who had undergone successful coronary stenting
60 mcg48 mg26 weeks—
Changes in basal and postmethionine load concentrations of total homocysteine and cystathionine after B vitamin intervention
2004 · group A · Patients with suspected coronary artery disease; age and sex not stated
400 mcg40 mg90 days—
One year B and D vitamins supplementation improves metabolic bone markers
2013 · group A · Healthy adults older than 54 years
500 mcg50 mg1 year—
Co-administration of methyl donors along with guanidinoacetic acid reduces the incidence of hyperhomocysteinaemia compared with guanidinoacetic acid administration alone
2013 · GAA with methyl donors group · Healthy male and female volunteers
5 mcg10 mg8 weeks—
Effects of mixed dietary supplements on total plasma homocysteine concentrations (tHcy): a randomized, double-blind, placebo-controlled trial
2012 · supplement group · hospitalized, acutely ill older patients recovering from acute illness; sex and age range not stated
1.5 mcg1.4 mg6 weeks—
One-carbon metabolites and telomere length in a prospective and randomized study of B- and/or D-vitamin supplementation
2017 · group A · Adults older than 54 years; no specific condition stated
500 mcg50 mg1 year—
MTHFR 677C → T genotype modulates the effect of a 5-year supplementation with B-vitamins on homocysteine concentration: The SU.FOL.OM3 randomized controlled trial
2018 · Group C: B-vitamins and n-3 fatty acids · Adults with a history of cardiovascular disease, including men and women; mean age 61.3 years
20 mcg3 mg1716 days—
Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation
2004 · folic acid, vitamin B12, and vitamin B6 group · Patients undergoing coronary angiography
400 mcg40 mg1 year—